RNA editing: Rewriting receptors  by O’Connell, Mary A.
Dispatch R437
RNA editing: Rewriting receptors
Mary A. O’Connell 
The type of RNA editing that converts adenosine to
inosine in double-stranded RNA generates different
isoforms of subunits of the ionotropic glutamate-gated
ion channel receptors. Recently, it has been reported
that the pre-mRNA of the serotonin 2C receptor can be
edited by the same mechanism.
Address: Department of Cell Biology, Biozentrum of the University of
Basel, Klingelberstrasse 70, CH-4056 Basel, Switzerland.
E-mail: oconnell@ubaclu.unibas.ch
Current Biology 1997, 7:R437–R439
http://biomednet.com/elecref/09609822007R0437
© Current Biology Ltd ISSN 0960-9822
In good detective novels, the body is usually discovered
first and the remainder of the novel is spent seeking the
culprit. For the most part, research on RNA editing — the
process by which the base sequence in RNA is altered
after transcription so it differs from the DNA sequence of
the gene — has faithfully followed this plot: the discovery
of edited RNAs has been followed by an intense search for
the enzymes responsible. But the type of RNA editing
that converts adenosine to inosine in double-stranded
RNA (dsRNA) has turned this plot upside down with the
discovery of the enzymatic activity first, followed by the
search to discover target RNAs. This search is bearing
fruit, with the recent discovery that the pre-mRNA for the
serotonin 2C receptor, like that for glutamate-gated
channel proteins, is edited in this way.
A dsRNA-specific adenosine deaminase activity was first
described in Xenopus laevis [1,2]. This activity, found in
every metazoan tested, converts adenosine to inosine in
dsRNA by hydrolytic deamination [3]. Inosine base-pairs
with cytidine when cDNA is made from the edited RNA,
and so the editing event will appear as a conversion of
adenosine to guanosine. Unlike other RNA editing, this
type does not require cofactors, guide RNAs nor specific
sequence motifs surrounding the edited adenosine. Speci-
ficity is achieved by the formation of an intramolecular
base-pairing interaction that folds the editing sites into a
double-stranded conformation (Figure 1). In extended
dsRNA, any adenosine can be deaminated while following
certain preference rules [4]. This type of hypermutation
has been observed in the cDNAs encoding the matrix
protein of measles virus [5] and in other negative strand
viruses [6]. The only other example of this type of hyper-
mutation has been reported in Drosophila [7].
Unexpectedly, a family of dsRNA adenosine deaminases
was found on the basis of sequence homology between
different members. To date, three mammalian members
of this family have been identified: dsRNA-specific
adenosine deaminase (DRADA/dsRAD/ADAR1) [8],
dsRNA-specific editase 1 (RED1/ADAR2) [9–13] and
dsRNA-specific editase 2 (RED2/ADAR3) [14]. Even
though ADAR3 has 50% sequence identity to ADAR2, it
cannot convert adenosine to inosine in extended dsRNA
and no target RNA has yet been found for it [14]. All three
enzymes contain two or three dsRNA-binding domains in
their amino-terminal region and a deaminase domain near
their carboxyl terminus [8]. Homologues have been puri-
fied and cloned from other species including X. laevis, and
other cDNAs have been suggested to encode proteins
with a high degree of homology to this deaminase family
[15]. Despite this, a specific correlation between enzyme
and target RNA has only been made for ADAR1 and
ADAR2 [9,10,12].
All the studies on the editing of specific pre-mRNAs by
ADAR1 and ADAR2 have been done in vitro. ADAR1 is
probably the most abundant protein in the family (being
expressed in most mammalian tissues, as observed by
northern analysis [16,17]) and was the first member of the
family to be purified and cloned from different sources [8].
It was proposed that this enzyme acts on the pre-mRNA of
the glutamate-gated receptor channels subunit B (GluR-B),
Figure 1
The dsRNA adenosine deaminases bind to the dsRNA via their dsRNA
binding domains. ADAR1 contains three such domains; ADAR2 and
ADAR3 both contain two. Duplex RNA is formed between exonic
(black line) and intronic sequences (gray line) in the pre-mRNA for
glutamate receptor channel proteins and the serotonin 2C receptor.
The catalytic deaminase domain responsible for the conversion of
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RNA
converting a glutamate (CAG) codon to an arginine (CIG)
codon at what has become known as the Q/R site (Q indi-
cating glutamate and R arginine in the single letter amino-
acid code). The converted glutamate is located in the
second transmembrane region, which participates in the
formation of the central channel between the various sub-
units, through which ions can diffuse. 
Conversion of the specific glutamate to an arginine renders
GluR-B-containing channels impermeable to Ca2+ ions,
with a major effect on the cell — Ca2+ ions being intracellu-
lar messengers that activate many cellular functions [18].
The edited GluR-B subunit is solely responsible for the
impermeability to Ca2+ of a-amino-3-hydroxy-5-methyl-4-
isoazole-propionic acid (AMPA) receptors, a subclass of glu-
tamate receptors [19]. This RNA editing event is
dependent on the maintenance of a duplex RNA structure
between exonic and nearby intronic sequences [20], and
inosine was shown to be incorporated into the mRNA at
this edited position [21–23]. After extensive speculation
that a specific cofactor allows ADAR1 to mediate this
editing event, work in several laboratories eventually led
to the identification of a related enzyme, ADAR2, which
alone is responsible for editing the Q/R site in GluR-B
pre-mRNA [9,10]. Further analysis showed that ADAR1
can edit the adenosine at the hotspot 1 site in the intron in
GluR-B pre-mRNA, whereas both enzymes can edit the
adenosine at the downstream R/G site [9,10]. 
Eight sites have been found in glutamate receptor
mRNAs where specific adenosines are edited [24]. There
is editing at the R/G site in the pre-mRNAs for GluR-C
and GluR-D, but these have not been investigated
further. The kainate receptor subunits GluR-5 and GluR-
6, which are distantly related to the AMPA receptor sub-
units, are also edited at their Q/R site in the second
transmembrane region by ADAR1 [25]. In the first trans-
membrane region of GluR-6, there are two edited sites
termed I/V and Y/C, but it is not known which enzyme
edits them [24]. It must be emphasized that it is only the
adenosine at the Q/R site in GluR-B mRNA that is edited
more than 99% of the time, all other sites being edited to a
lesser extent. The degree of editing can also vary during
development, an example being the R/G site in GluR-B
pre-mRNA [26]. 
Recently, it has been reported that the pre-mRNAs
encoding the human homologues of ADAR1 [27] and
ADAR2 [11–13] are alternatively spliced. The conse-
quence of the alternative splicing of hADAR1 is unclear,
as it only has an observable effect if the dsRNA-binding
domains are also mutated [27]. There are four alterna-
tively spliced variants of hADAR2, generated by two alter-
native splicing events. One alternative splicing event
results in differential insertion of an Alu cassette into the
region encoding the deaminase domain of hADAR2: the
forms of the enzyme that include the region encoded by the
Alu casette have an editing activity that is two-fold lower
than the shorter variants [12]. They may have an important
function in vivo, as many sites in the GluR-B pre-mRNAs
are only partially edited and the spliced variants may there-
fore play a role in modulating editing activity.
One major problem in the study of dsRNA adenosine
deaminases has been the lack of mammalian target RNAs
other than the pre-mRNAs encoding glutamate receptor
subunits. Therefore, much excitement has been generated
by the recent paper of Burns et al. [28] reporting the
editing of the pre-mRNA of the serotonin 2C receptor.
This is the first example of RNA editing in the pre-mRNA
encoding a G-protein-coupled receptor, raising the possi-
bility that more members of this class of receptors are
edited. This editing event is a conversion of specific
adenosines to inosines and it occurs at four positions,
termed sites A, B, C and D, which lie close together within
a 12 nucleotide duplex structure (Figure 2). The editing
alters the amino acid composition in the predicted second
intracellular loop of the receptor, resulting in eleven differ-
ent mRNAs that encode seven major serotonin 2C iso-
forms (Figure 2). The fully edited version of the receptor,
termed VSV, interacts with downstream G proteins 10–15-
fold less efficiently than the unedited version, whereas the
other isoforms appear to exhibit the same behavior as the
unedited form. 
The serotonin 2C pre-mRNAs are edited by ADAR1 and
ADAR2. Although there are some discrepancies between
the site selectivity observed by in vitro editing and that
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Figure 2
The editing of the serotonin 2C receptor pre-mRNA at the four sites A,
B, C and D converts the amino acids INI to VSV. The nucleotide
sequence is shown above, and the changes are summarized in the table
below. *Editing at site B is always accompanied by editing at site A.
	 A	 B	 C	 D
Unedited	 ATA	 GTA*	 AAT	 ATT
Edited	 GTA	 GTG	 AGT	 GTT
Amino acids	 I     V	 I     V	 N     S	 I     V
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Editing site:	 A B	 C	 D
	 V	 A	 I	 R	 N	 P	 I	 E	 H
Genomic	 GTA	 GCA	 ATA	 CGT	 AAT	CCT	 ATT	GAG	CAT
cDNA	 GTA	 GCA	GTG	CGT	 AGT	CCT	 GTT	GAG	CAT
	 V	 A	 V	 R	 S	 P	 V	 E	 H
seen in co-transfection experiments, it appears that
ADAR1 edits sites A, B and C, while ADAR2 has the
strongest preference for the D site. Analysis of serotonin
2C mRNA from different regions of the brain reveals a
tissue-specific expression pattern of the different iso-
forms, with editing at the A, B and D sites being the most
common variant found in whole brain and hippocampus.
This is another example where editing by ADAR1 can
vary drastically at three sites which are located within 12
nucleotides, and this fluctuation in editing particular
adenosines varies in different regions of the brain. These
results strongly suggest that cofactors may be involved in
selecting or masking particular adenosines; alternatively,
the different splice variants of the dsRNA adenosine
deaminases may play a role.
The work by Burns et al. [28], as well as the earlier work of
Seeburg and colleagues [18], has firmly established that
RNA editing of pre-mRNAs encoding receptors in the
brain by members of the family of dsRNA adenosine
deaminases is a widespread phenomenon, generating many
diverse receptor isoforms. Physiological pre-mRNA targets
for RNA editing have, until now, only been found in the
central nervous system. However, dsRNA-specific adeno-
sine deaminases are present in essentially all tissues and
one of the challenges of the future will be to identify addi-
tional RNA targets outside of the brain. Another important
goal will be to determine the detailed molecular interaction
between the different types of editing enzymes and their
substrates, and to elucidate the mechanisms that control
the efficiency of the reaction at different sites.
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